Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Le Infezioni in Medicina|June 1, 2021
Prevalence of resistance-associated substitutions to NS3, NS5A and NS5B inhibitors at DAA-failure in hepatitis C virus in Italy from 2015 to 2019Barbara Rossetti, Lorenzo Paglicci, Velia C Di Maio, et al.
Open Forum Infectious Diseases|October 30, 2019
Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced PatientsFlaminia Olearo, Huyen Nguyen, Fabrice Bonnet, et al.
The Patient|May 30, 2020
Correction to: Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral SuppressionAndrea Antinori, Maria V Cossu, Barbara Menzaghi, et al.
The Patient|April 9, 2020
Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral SuppressionAndrea Antinori, Maria V Cossu, Barbara Menzaghi, et al.
Viruses|September 28, 2024
Comparison of Different HIV-1 Resistance Interpretation Tools for Next-Generation Sequencing in ItalyDaniele Armenia, Luca Carioti, Valeria Micheli, et al.
Journal of Medical Virology|December 29, 2025
Durability of Long-Acting Cabotegravir + Rilpivirine in Virologically Suppressed Adults Living With HIV: A Multicenter Observational Cohort in Tuscany (LAHIV)Filippo Lagi, Giuseppe Formica, Massimiliano Fabbiani, et al.
Plos One|November 22, 2017
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-week results of a randomized trialBarbara Rossetti, Roberta Gagliardini, Genny Meini, et al.
Journal of Viral Hepatitis|July 29, 2024
Hepatitis C epidemiology and treatment outcomes in Italy: Impact of the DAA era and the COVID-19 pandemicMaria Paola Tramonti Fantozzi, Luca Ceccarelli, Davide Petri, et al.
Viruses|February 28, 2023
Safety and Efficacy of Outpatient Treatments for COVID-19: Real-Life Data from a Regionwide Cohort of High-Risk Patients in Tuscany, Italy (the FEDERATE Cohort)Tommaso Manciulli, Michele Spinicci, Barbara Rossetti, et al.
Microorganisms|October 26, 2024
The Uprise of Human Leishmaniasis in Tuscany, Central Italy: Clinical and Epidemiological Data from a Multicenter StudyAnna Barbiero, Michele Spinicci, Andrea Aiello, et al.
Pageof 7